Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis

Pengda Liu, Wenjian Gan, Hiroyuki Inuzuka, Adam S. Lazorchak, Daming Gao, Omotooke Arojo, Dou Liu, Lixin Wan, Bo Zhai, Yonghao Yu, Min Yuan, Byeong Mo Kim, Shavali Shaik, Suchithra Menon, Steven P. Gygi, Tae Ho Lee, John M. Asara, Brendan D. Manning, John Blenis, Bing Su & 1 others Wenyi Wei

Research output: Contribution to journalArticle

126 Citations (Scopus)

Abstract

The mechanistic target of rapamycin (mTOR) functions as a critical regulator of cellular growth and metabolism by forming multi-component, yet functionally distinct complexes mTORC1 and mTORC2. Although mTORC2 has been implicated in mTORC1 activation, little is known about how mTORC2 is regulated. Here we report that phosphorylation of Sin1 at Thr 86 and Thr 398 suppresses mTORC2 kinase activity by dissociating Sin1 from mTORC2. Importantly, Sin1 phosphorylation, triggered by S6K or Akt, in a cellular context-dependent manner, inhibits not only insulin- or IGF-1-mediated, but also PDGF- or EGF-induced Akt phosphorylation by mTORC2, demonstrating a negative regulation of mTORC2 independent of IRS-1 and Grb10. Finally, a cancer-patient-derived Sin1-R81T mutation impairs Sin1 phosphorylation, leading to hyper-activation of mTORC2 by bypassing this negative regulation. Together, our results reveal a Sin1-phosphorylation-dependent mTORC2 regulation, providing a potential molecular mechanism by which mutations in the mTORC1-S6K-Sin1 signalling axis might cause aberrant hyper-activation of the mTORC2-Akt pathway, which facilitates tumorigenesis.

Original languageEnglish (US)
Pages (from-to)1340-1350
Number of pages11
JournalNature Cell Biology
Volume15
Issue number11
DOIs
StatePublished - Nov 2013

Fingerprint

Carcinogenesis
Phosphorylation
TOR complex 2
Mutation
Sirolimus
Insulin-Like Growth Factor I
Epidermal Growth Factor
Phosphotransferases
Insulin
Growth
mechanistic target of rapamycin complex 1
Neoplasms

ASJC Scopus subject areas

  • Cell Biology

Cite this

Liu, P., Gan, W., Inuzuka, H., Lazorchak, A. S., Gao, D., Arojo, O., ... Wei, W. (2013). Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis. Nature Cell Biology, 15(11), 1340-1350. https://doi.org/10.1038/ncb2860

Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis. / Liu, Pengda; Gan, Wenjian; Inuzuka, Hiroyuki; Lazorchak, Adam S.; Gao, Daming; Arojo, Omotooke; Liu, Dou; Wan, Lixin; Zhai, Bo; Yu, Yonghao; Yuan, Min; Kim, Byeong Mo; Shaik, Shavali; Menon, Suchithra; Gygi, Steven P.; Lee, Tae Ho; Asara, John M.; Manning, Brendan D.; Blenis, John; Su, Bing; Wei, Wenyi.

In: Nature Cell Biology, Vol. 15, No. 11, 11.2013, p. 1340-1350.

Research output: Contribution to journalArticle

Liu, P, Gan, W, Inuzuka, H, Lazorchak, AS, Gao, D, Arojo, O, Liu, D, Wan, L, Zhai, B, Yu, Y, Yuan, M, Kim, BM, Shaik, S, Menon, S, Gygi, SP, Lee, TH, Asara, JM, Manning, BD, Blenis, J, Su, B & Wei, W 2013, 'Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis', Nature Cell Biology, vol. 15, no. 11, pp. 1340-1350. https://doi.org/10.1038/ncb2860
Liu, Pengda ; Gan, Wenjian ; Inuzuka, Hiroyuki ; Lazorchak, Adam S. ; Gao, Daming ; Arojo, Omotooke ; Liu, Dou ; Wan, Lixin ; Zhai, Bo ; Yu, Yonghao ; Yuan, Min ; Kim, Byeong Mo ; Shaik, Shavali ; Menon, Suchithra ; Gygi, Steven P. ; Lee, Tae Ho ; Asara, John M. ; Manning, Brendan D. ; Blenis, John ; Su, Bing ; Wei, Wenyi. / Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis. In: Nature Cell Biology. 2013 ; Vol. 15, No. 11. pp. 1340-1350.
@article{939df491510644e4b54734184d162a48,
title = "Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis",
abstract = "The mechanistic target of rapamycin (mTOR) functions as a critical regulator of cellular growth and metabolism by forming multi-component, yet functionally distinct complexes mTORC1 and mTORC2. Although mTORC2 has been implicated in mTORC1 activation, little is known about how mTORC2 is regulated. Here we report that phosphorylation of Sin1 at Thr 86 and Thr 398 suppresses mTORC2 kinase activity by dissociating Sin1 from mTORC2. Importantly, Sin1 phosphorylation, triggered by S6K or Akt, in a cellular context-dependent manner, inhibits not only insulin- or IGF-1-mediated, but also PDGF- or EGF-induced Akt phosphorylation by mTORC2, demonstrating a negative regulation of mTORC2 independent of IRS-1 and Grb10. Finally, a cancer-patient-derived Sin1-R81T mutation impairs Sin1 phosphorylation, leading to hyper-activation of mTORC2 by bypassing this negative regulation. Together, our results reveal a Sin1-phosphorylation-dependent mTORC2 regulation, providing a potential molecular mechanism by which mutations in the mTORC1-S6K-Sin1 signalling axis might cause aberrant hyper-activation of the mTORC2-Akt pathway, which facilitates tumorigenesis.",
author = "Pengda Liu and Wenjian Gan and Hiroyuki Inuzuka and Lazorchak, {Adam S.} and Daming Gao and Omotooke Arojo and Dou Liu and Lixin Wan and Bo Zhai and Yonghao Yu and Min Yuan and Kim, {Byeong Mo} and Shavali Shaik and Suchithra Menon and Gygi, {Steven P.} and Lee, {Tae Ho} and Asara, {John M.} and Manning, {Brendan D.} and John Blenis and Bing Su and Wenyi Wei",
year = "2013",
month = "11",
doi = "10.1038/ncb2860",
language = "English (US)",
volume = "15",
pages = "1340--1350",
journal = "Nature Cell Biology",
issn = "1465-7392",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Sin1 phosphorylation impairs mTORC2 complex integrity and inhibits downstream Akt signalling to suppress tumorigenesis

AU - Liu, Pengda

AU - Gan, Wenjian

AU - Inuzuka, Hiroyuki

AU - Lazorchak, Adam S.

AU - Gao, Daming

AU - Arojo, Omotooke

AU - Liu, Dou

AU - Wan, Lixin

AU - Zhai, Bo

AU - Yu, Yonghao

AU - Yuan, Min

AU - Kim, Byeong Mo

AU - Shaik, Shavali

AU - Menon, Suchithra

AU - Gygi, Steven P.

AU - Lee, Tae Ho

AU - Asara, John M.

AU - Manning, Brendan D.

AU - Blenis, John

AU - Su, Bing

AU - Wei, Wenyi

PY - 2013/11

Y1 - 2013/11

N2 - The mechanistic target of rapamycin (mTOR) functions as a critical regulator of cellular growth and metabolism by forming multi-component, yet functionally distinct complexes mTORC1 and mTORC2. Although mTORC2 has been implicated in mTORC1 activation, little is known about how mTORC2 is regulated. Here we report that phosphorylation of Sin1 at Thr 86 and Thr 398 suppresses mTORC2 kinase activity by dissociating Sin1 from mTORC2. Importantly, Sin1 phosphorylation, triggered by S6K or Akt, in a cellular context-dependent manner, inhibits not only insulin- or IGF-1-mediated, but also PDGF- or EGF-induced Akt phosphorylation by mTORC2, demonstrating a negative regulation of mTORC2 independent of IRS-1 and Grb10. Finally, a cancer-patient-derived Sin1-R81T mutation impairs Sin1 phosphorylation, leading to hyper-activation of mTORC2 by bypassing this negative regulation. Together, our results reveal a Sin1-phosphorylation-dependent mTORC2 regulation, providing a potential molecular mechanism by which mutations in the mTORC1-S6K-Sin1 signalling axis might cause aberrant hyper-activation of the mTORC2-Akt pathway, which facilitates tumorigenesis.

AB - The mechanistic target of rapamycin (mTOR) functions as a critical regulator of cellular growth and metabolism by forming multi-component, yet functionally distinct complexes mTORC1 and mTORC2. Although mTORC2 has been implicated in mTORC1 activation, little is known about how mTORC2 is regulated. Here we report that phosphorylation of Sin1 at Thr 86 and Thr 398 suppresses mTORC2 kinase activity by dissociating Sin1 from mTORC2. Importantly, Sin1 phosphorylation, triggered by S6K or Akt, in a cellular context-dependent manner, inhibits not only insulin- or IGF-1-mediated, but also PDGF- or EGF-induced Akt phosphorylation by mTORC2, demonstrating a negative regulation of mTORC2 independent of IRS-1 and Grb10. Finally, a cancer-patient-derived Sin1-R81T mutation impairs Sin1 phosphorylation, leading to hyper-activation of mTORC2 by bypassing this negative regulation. Together, our results reveal a Sin1-phosphorylation-dependent mTORC2 regulation, providing a potential molecular mechanism by which mutations in the mTORC1-S6K-Sin1 signalling axis might cause aberrant hyper-activation of the mTORC2-Akt pathway, which facilitates tumorigenesis.

UR - http://www.scopus.com/inward/record.url?scp=84887228819&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887228819&partnerID=8YFLogxK

U2 - 10.1038/ncb2860

DO - 10.1038/ncb2860

M3 - Article

VL - 15

SP - 1340

EP - 1350

JO - Nature Cell Biology

JF - Nature Cell Biology

SN - 1465-7392

IS - 11

ER -